GENTIBIO

GentiBio is a biotherapeutics company developing engineered regulatory T cells (EngTregs) programmed to treat autoimmune allergic diseases. The early-stage biotherapeutics company co-founded by pioneers in Treg biology and synthetic immunology to develop engineered regulatory T cells (EngTregs) programmed to treat autoimmune, alloimmune, autoinflammatory, and allergic diseases. GentiBio's proprietary autologous and allogeneic EngTregs platform integrates key complementary technologies needed to... successfully restore immune tolerance and overcome major limitations in existing regulatory T-cell therapeutics. GentiBio is at the forefront of leveraging a unique therapeutic modality that can be used to address the fundamental cause of many diseases that result from overshooting and/or malfunctioning of the immune system. GentiBio is a Seattle, Washington-headquartered company launched in 2020 by Adel Nada, Chandra Patel, and Andy Walker.

#SimilarOrganizations #People #Financial #Event #Website #More

GENTIBIO

Social Links:

Industry:

Biotechnology Life Science

Founded:

2020-01-01

Address:

Seattle, Washington, United States

Country:

United States

Website Url:

http://www.gentibio.com

Total Employee:

Status:

Active

Total Funding:

177 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt WordPress Wordpress Plugins Nginx Sitelinks Search Box

Similar Organizations

aavantibio-logo

AavantiBio

AavantiBio is a biopharmaceutical company that provides gene transfer and gene editing therapies to treat genetic diseases.

enliven-therapeutics-logo

Enliven Therapeutics

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.

novellus-logo

Novellus

Novellus is a biotechnology company working to develop engineered cellular medicines.

renovacor-logo

Renovacor

Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.

vigil-neuroscience-logo

Vigil Neuroscience

Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.

Current Advisors List

nathaniel-brooks-horwitz_image

Nathaniel Brooks Horwitz Board Director @ GentiBio
Board_member
2020-01-01

Current Employees Featured

adel-nada_image

Adel Nada
Adel Nada Co-founder, President and CEO @ GentiBio
Co-founder, President and CEO
2020-01-01

andy-walker_image

Andy Walker
Andy Walker Co-founder & Chief Technology Officer @ GentiBio
Co-founder & Chief Technology Officer
2020-01-01

chandra-patel_image

Chandra Patel
Chandra Patel Co-founder, Vice President R&D Operations @ GentiBio
Co-founder, Vice President R&D Operations
2020-01-01

neely-mozaffarian_image

Neely Mozaffarian
Neely Mozaffarian Chief Medical Officer @ GentiBio
Chief Medical Officer
2022-06-01

chuck-silberstein_image

Chuck Silberstein
Chuck Silberstein Chief Financial Officer @ GentiBio
Chief Financial Officer
2022-02-01

Founder

adel-nada_image

Adel Nada

andy-walker_image

Andy Walker

chandra-patel_image

Chandra Patel

Investors List

jdrf-t1d-fund_image

Key Employee Changes

Date	New article
2022-06-01	GentiBio Appoints Neely Mozaffarian, MD, PhD as Chief Medical Officer
2022-02-10	GentiBio Appoints Industry Veteran Chuck Silberstein as Chief Financial Officer

Official Site Inspections

http://www.gentibio.com

Host Informations
Whois Informations

Loading ...